NPPA Fixes Retail Price Of 51 Formulations, Details

New Delhi : Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 51 formulations, including pain killers, pulmonary drugs, and those used to treat high blood pressure, type 2 diabetes, and bacterial infections.

This came in line with the decision of the 116th Authority meeting dated 6.09.2023, where the authority discussed the new drug applications for price fixation under para 5 and 15 of drugs prices control order, 2013 (DPCO 2013).

These include Synokem pharmaceutical/Torrent Pharmaceutical’s fixed dose combination Rosuvastatin plus Clopidogrel Capsules, Daiwik Pharmasphere/ Aristo Pharmaceuticals’ Diclofenac Diethylamine, Methyl Salicylate and Menthol Gel, Exemed Pharmaceuticals/Abbott Healthcare’s Linagliptin and Metformin Hydrochloride Tablets, Sai Primus Life Biotech/Primus Remedies’ Linagliptin plus Metformin Hydrochloride Tablet.

The list further includes, Skymap Pharmaceuticals’ Linagliptin plus Metformin Hydrochloride Tablet, Skymap Pharmaceuticals/ Glensmith Labs’ Linagliptin plus Metformin Hydrochloride Tablet, Skymap Pharmaceuticals’ Linagliptin plus Metformin Hydrochloride Tablet, Lucent Biotech/Torrent Pharmaceutical’s Pantoprazole Sodium (EC) & Levosulpiride (SR) Capsules.

The retail prices for the fixed-dose combinations of Linagliptin and Metformin Hydrochloride Tablets manufactured and marketed by Macleods Pharmaceuticals, Linagliptin and Metformin Hydrochloride (ER) Tablets manufactured and marketed by Synokem Pharmaceuticals and Cipla, and Cefuroxime Axetil and Potassium Clavulanate FDC Tablets manufactured and marketed by Hetero Labs and Sun Pharmaceuticals, have also been set.

This comes in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (NPPA), has fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Sl.

No.

Name of the

Formulation / Brand Name

Strength

Unit

Manufacturer &

Marketing Company

Retail

Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

1

Rosuvastatin & Clopidogrel Capsules

Each hard gelatin capsule contains:

Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (as Pellets)

Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As

Pellets)

1

Capsule

M/s Synokem Pharmaceuticals Ltd / M/s Torrent Pharmaceuticals Limited

18.95

2

Diclofenac Diethylamine, Methyl Salicylate and Menthol Gel

Composition:

Diclofenac Diethylamine IP

2.32 % w/w eq. to Diclofenac Sodium IP 2.0 % w/w Methyl Salicylate IP 10 % w/w

Menthol IP 5 % w/w

1 Gram

M/s Daiwik Pharmasphere Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.

4.08

3

Linagliptin and Metformin Hydrochloride Tablets

Each film coated tablet contains:

Linagliptin 2.5mg Metformin Hydrochloride IP

500mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Abbott Healthcare Pvt.

Ltd.

8.97

4

Linagliptin + Metformin Hydrochloride Tablet

Each film coated tablet contains:

Linagliptin 2.5mg

Metformin Hydrochloride IP 850mg

1 Tablet

M/s Sai Primus Life Biotech Private Limited /

M/s Primus Remedies Pvt. Ltd.

12.18

5

Linagliptin + Metformin Hydrochloride Tablet

Each film coated tablet contains:

Linagliptin 2.5mg Metformin Hydrochloride IP

1000mg

1 Tablet

M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Glensmith Labs

Pvt. Ltd.

9.60

 

Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

6

Linagliptin + Metformin Hydrochloride Tablet

Each film coated tablet contains:

Linagliptin 2.5mg Metformin Hydrochloride IP

500mg

1 Tablet

M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Glensmith Labs Pvt. Ltd.

8.97

7

Linagliptin + Metformin Hydrochloride Tablet

Each film coated tablet contains:

Linagliptin 2.5mg

Metformin Hydrochloride IP 500mg

1 Tablet

M/s Skymap Pharmaceuticals Pvt. Ltd.

8.97

8

Linagliptin + Metformin Hydrochloride Tablet

Each film coated tablet contains:

Linagliptin 2.5mg Metformin Hydrochloride IP

1000mg

1 Tablet

M/s Skymap Pharmaceuticals Pvt. Ltd.

9.60

9

Linagliptin and Metformin Hydrochloride Tablets

Each film coated tablet contains:

Linagliptin 2.5mg Metformin Hydrochloride IP

1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Abbott Healthcare Pvt.

Ltd.

9.60

10

Pantoprazole Sodium (EC) & Levosulpiride (SR) Capsules

Each Hard gelatine capsule contains:

Pantoprazole Sodium Sesquihydrate IP eq. to Pantoprazole 40mg (As Enteric Coated Pellets) Levosulpiride 75mg (As

Sustained Release Pellets)

1

Capsule

M/s Lucent Biotech Limited / M/s Torrent Pharmaceuticals Ltd.

15.96

11

Budesonide and Formoterol Fumarate

Each 2 ml respule contains: Budesonide IP 1mg Formoterol Fumarate Dihydrate eq. to Formoterol Fumarate 20

mcg

Per 2 ml

M/s Axa Parenterals Ltd./ M/s J.B. Chemicals & Pharmaceuticals Ltd.

56.20

12

Itraconazole Capsules (Supra- Bioavailable Formulation)

Each Hard gelatine capsule contains:

(Supra-Bioavailable formulation) Itraconazole IP 130mg

1

Capsule

M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Dr. Reddy’s Laboratories

Limited

19.30

13

Linagliptin + Metformin Hydrochloride Extended Release Tablet

Each film coated bilayer tablet contains: Linagliptin 2.5mg Metformin Hydrochloride (As extended release)IP 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.

9.60

14

Linagliptin + Metformin Hydrochloride Tablet

Each film coated tablet contains:

Linagliptin 2.5mg

Metformin Hydrochloride IP 500mg

1 Tablet

M/s Macleods Pharmaceuticals Ltd.

8.97

Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

15

Linagliptin + Metformin Hydrochloride Tablet

Each film coated tablet contains:

Linagliptin 2.5mg Metformin Hydrochloride IP

1000mg

1 Tablet

M/s Macleods Pharmaceuticals Ltd.

9.60

16

Linagliptin + Metformin Hydrochloride (ER) Tablet

Each film coated bilayered tablet contains:

Linagliptin 2.5mg Metformin Hydrochloride IP 1000mg (as Extended

release)

1 Tablet

M/s Synokem Pharmaceuticals Ltd. / M/s Cipla Ltd.

9.60

17

Itraconazole Capsules (Supra- Bioavailable Formulation)

Each Hard gelatine capsule contains:

(Supra-Bioavailable formulation) Itraconazole IP 65mg

1

Capsule

M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Dr. Reddy’s Laboratories Limited

10.81

18

Diclofenac Potassium & Metaxalone Tablets

Each uncoated tablet contains:

Diclofenac Potassium IP 50mg

Metaxalone USP 400mg

1 Tablet

M/s Windlas Biotech Limited / M/s Intas Pharmaceuticals Ltd.

15.08

19

Cefuroxime Axetil & Potassium Clavulanate Tablets

Each film coated tablet contains:

Cefuroxime Axetil IP eq. to Cefuroxime 500mg Potassium Clavulanate Diluted IP Eq. to Clavulanic

Acid 125mg

1 Tablet

M/s Hetero Labs Limited / M/s Sun Pharmaceuticals Industries Limited

55.23

20

Levosalbutamol and Ipratropium Bromide respule solution

Each 2.5ml contains: Levosalbutamol Sulphate IP eq. to Levosalbutamol 1.25mg

Ipratropium Bromide IP eq. to Ipratropium (anhydrous)

500mcg

1 ML

M/s AXA Parenterals Ltd. / M/s Mankind Pharma Ltd.

5.49

21

Moxifloxacin Eye Drops

Composition: Moxifloxacin hydrochloride IP eq. to Moxofloxacin 0.5%w/v

Preservative : Benzalkonium Chloride

Solution IP 0.02% w/v

1 ML

M/s East African (India) Overseas / M/s Torrent Pharmaceuticals Limited

17.00

22

Pantoprazole Dual Release Gastro Resistant Tablets

Each Dual Release Gastro Resistant Tablet Contains: Pantoprazole Sodium IP eq. to Pantoprazole 80mg

1 Tablet

M/s Pure & Cure Healthcare Pvt. Ltd. / M/s

Mankind Pharma Ltd.

15.30

23

Telmisartan, Chlorthalidone & Cilnidipine tablets

Each film coated tablet contains:

Telmisartan IP 40mg Chlorthalidone IP 6.25mg

Cilnidipine IP 10mg

1 Tablet

M/s Macleods Pharmaceuticals Ltd.

13.05

Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

24

Povidone Iodine Gargle

Composition:

Povidone Iodine IP 0.5% w/v (available Iodine 0.05% w/v)

1 ml

M/s Pontika Aerotech Limited / M/s Emcure Pharmaceuticals Limited

0.70

25

Teneligliptin, Pioglitazone and Metformin Hydrochloride (as Sustained Release) Tablets

Each Film coated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin 20mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP 500mg (as Sustained Release)

1 Tablet

M/s Synokem Pharmaceuticals Limited / M/s Micro Labs Limited

16.07

26

Teneligliptin, Pioglitazone and Metformin Hydrochloride (as Sustained Release) Tablets

Each Film coated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin 20mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP 1000mg (as Sustained

Release)

1 Tablet

M/s Synokem Pharmaceuticals Limited / M/s Micro Labs Limited

17.85

27

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet

Each film coated Bilayered Tablet Contain:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP

500mg (Sustained Release Form)

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd.

16.06

28

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet

Each film coated Bilayered Tablet Contain:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP

500mg (Sustained Release Form)

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s Eris Lifesciences Limited

16.06

29

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet

Each film coated Bilayered Tablet Contain:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg

Metformin Hydrochloride IP

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Intas Pharmaceuticals Ltd.

16.06

Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

500mg (Sustained Release Form)

30

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet

Each film coated Bilayered Tablet Contain:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP

500mg (Sustained Release Form)

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd.

16.09

31

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet

Each film coated Bilayered Tablet Contain:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP

500mg (Sustained Release Form)

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s La Renon Healthcare Private Limited

16.09

32

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet

Each film coated Bilayered Tablet Contain:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release

Form)

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd.

17.13

33

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet

Each film coated Bilayered Tablet Contain:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release

Form)

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s Eris Lifesciences Limited

17.13

34

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet

Each film coated Bilayered Tablet Contain:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release

Form)

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Intas Pharmaceuticals Ltd.

17.13

Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

35

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet

Each film coated Bilayered Tablet Contain:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release

Form)

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd.

17.16

36

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet

Each film coated Bilayered Tablet Contain:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP

1000mg (Sustained Release Form)

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s La Renon Healthcare Private Limited

17.16

37

Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayer tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin (As Sustained release) IP 100mg Metformin Hydrochloride IP (as Sustained Release)

500mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.

18.00

38

Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each uncoated bilayer tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Vildagliptin (As Sustained release) IP 100mg

Metformin Hydrochloride (as Sustained Release) IP 500mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Alkem Laboratories Limited

16.29

39

Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayer tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin (As Sustained release) IP 100mg Metformin Hydrochloride IP (as Sustained Release)

1000mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.

19.00

40

Dapagliflozin, Sitagliptin and Metformin

Each film coated tablet contains:

Dapagliflozin Propanediol Monohydrate eq. to

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Alkem

14.59

Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Hydrochloride (ER) Tablets

Dapagliflozin 5mg Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 50mg

Metformin Hydrochloride IP 1000mg (As Extende Release

form)

Laboratories Limited

41

Dapagliflozin, Sitagliptin and Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 50mg

Metformin Hydrochloride IP

500mg (As Extende Release form)

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Alkem Laboratories Limited

13.62

42

Linagliptin + Metformin Hydrochloride Extended Release Tablet

Each film coated bilayer tablet contains: Linagliptin 5mg Metformin Hydrochloride

(As extended release) IP 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.

14.37

43

Linagliptin + Metformin Hydrochloride (ER) Tablet

Each film coated bilayered tablet contains:

Linagliptin 5mg

Metformin Hydrochloride IP

1000mg (as Extended release)

1 Tablet

M/s Synokem Pharmaceuticals Ltd. / M/s Cipla Ltd.

14.37

44

Linagliptin + Metformin Hydrochloride (ER) Tablet

Each film coated tablet contains:

Linagliptin 5mg

Metformin Hydrochloride (as Extended release) IP 1000mg

1 Tablet

M/s Exemed Pharmaceuticals Ltd. / M/s Micro Labs Ltd.

14.37

45

Linagliptin + Metformin Hydrochloride (ER) Tablet

Each film coated bilayered tablet contains:

Linagliptin 5mg

Metformin Hydrochloride (as Extended release) IP 1000mg

1 Tablet

M/s Synokem Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd.

14.00

46

Linagliptin + Metformin Hydrochloride (ER) Tablet

Each film coated bilayered tablet contains:

Linagliptin 5mg

Metformin Hydrochloride (as Extended release) IP 1000mg

1 Tablet

M/s Synokem Pharmaceuticals Ltd. / M/s Lupin Limited

14.37

47

Metoprolol Succinate Extended Release,

Amlodipine 5mg

Each film coated bilayered tablet contains:

Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate 50mg (As Extended

1 Tablet

M/s Ajanta Pharma Limited

14.23

Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

& Telmisartan Tablet

release)

Amlodipine Besilate IP IP eq. to Amlodipine 5mg Telmisartan IP 40mg

48

Ambroxol Hydrochloride, Salbutamol Sulphate, Guaiphenesin & Methol Liquid

Each 5ml contains: Ambroxol Hydrochloride IP 15mg

Salbutamol Sulphate IP eq. to Salbutamol 1mg Guaiphenesin IP 50mg

Methol IP 1mg

1 ml

M/s Naxpar Pharma Pvt. Ltd. / M/s Geno Pharmaceuticals Pvt. Ltd.

0.52

49

Glimepiride & Lobeglitazone Sulfate tablet

Each uncoated Bilayer tablet contains: Lobeglitazone Sulfate 0.5mg Glimepiride IP 1mg

1 Tablet

M/s Glenmark Pharmaceuticals Limited

11.39

50

Combikit of Clarithromycin Tablets IP, Esomeprazole Tablets IP & Amoxicillin Tablets USP

Each Strip contains:

A. Clarithromycin Tablets IP 2 Tablets

Each film coated tablet contains:

Clarithromycin IP 500mg

B. Esomeprazole Tablets IP 2 Tablets

Each Enteric coated tablet contains:

Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mg

C. Amoxicillin Tablets USP 2 Tablets

Each Film coated tablet contains:

Amoxycillin Trihydrate IP eq.

to Amoxycillin 1000mg

Each Strip

M/s Malik Lifesciences Pvt. Ltd. / M/s Cipla Limited

151.98

51

Brinzolamide, Brimonidine Tartrate & Timolol Ophthalmic suspension

Each ml contains: Brinzolamide IP 10mg Brimonidine Tartrate IP 2 mg

Timolol Maleate eq. to

Timolol IP 5 mg Water for injection

1 ml

M/s Micro labs Limited

105.25

The notification further added,

(a)The manufacturer of above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b)The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c)The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d)As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e)The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f)In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g)Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.

Related Posts

  • Pharma
  • June 20, 2024
  • 94 views
NMC Says No Antibiotics Before Diagnostic Tests

New Delhi: No antibiotics should be given without diagnostic tests proving that their use is warranted. This is the directive by the National Medical Commission (NMC), which has released a set…

  • Pharma
  • June 20, 2024
  • 114 views
Health, Drug Control Officials To Monitor Sale Of Abortion Kits

Bengaluru: Officers from the State Health Department and the Drugs Control Department in Karnataka will collaborate to conduct inspections of medical stores statewide, ensuring proper sale of MTP (Medical Termination…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NMC Says No Antibiotics Before Diagnostic Tests

NMC Says No Antibiotics Before Diagnostic Tests

Health, Drug Control Officials To Monitor Sale Of Abortion Kits

Health, Drug Control Officials To Monitor Sale Of Abortion Kits

Punjab: 11-Month-Old Given Expired Vaccine At Amritsar’s Private Hospital

Punjab: 11-Month-Old Given Expired Vaccine At Amritsar’s Private Hospital

Dermatologists Raise Concern Over Rising Skin Conditions In India

Dermatologists Raise Concern Over Rising Skin Conditions In India

Expert Panel To Soon Weigh Plan To Use Generics For Prescription Drugs

Expert Panel To Soon Weigh Plan To Use Generics For Prescription Drugs

Telangana Anti-Narcotics Bureau Seals Alprazolam Manufacturing Unit

Telangana Anti-Narcotics Bureau Seals Alprazolam Manufacturing Unit